Literature DB >> 26900284

Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Akiko Yamada1, Rieko Arakaki1, Masako Saito1, Takaaki Tsunematsu1, Yasusei Kudo1, Naozumi Ishimaru1.   

Abstract

Regulatory T (Treg) cells play key roles in various immune responses. For example, Treg cells contribute to the complex pathogenesis of inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis during onset or development of that disease. Many animal models of IBD have been used to investigate factors such as pathogenic cytokines, pathogenic bacteria, and T-cell functions, including those of Treg cells. In addition, analyses of patients with IBD facilitate our understanding of the precise mechanism of IBD. This review article focuses on the role of Treg cells and outlines the pathogenesis and therapeutic strategies of IBD based on previous reports.

Entities:  

Keywords:  Animal model; Inflammatory bowel disease; Regulatory T cell; Therapy

Mesh:

Substances:

Year:  2016        PMID: 26900284      PMCID: PMC4734996          DOI: 10.3748/wjg.v22.i7.2195

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  131 in total

1.  Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Yoshio Wakatsuki; Ivan J Fuss; Warren Strober
Journal:  Immunity       Date:  2006-08-31       Impact factor: 31.745

2.  CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.

Authors:  Markus Kleinewietfeld; Fabiola Puentes; Giovanna Borsellino; Luca Battistini; Olaf Rötzschke; Kirsten Falk
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

4.  The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor gamma(-/-) mice.

Authors:  Yukie Murata; Akira Yamashita; Takashi Saito; Kazuo Sugamura; Junji Hamuro
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

5.  Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.

Authors:  Zhe Li; Ingrid Arijs; Gert De Hertogh; Séverine Vermeire; Maja Noman; Dominique Bullens; Lieve Coorevits; Xavier Sagaert; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens; Gert Van Assche
Journal:  Inflamm Bowel Dis       Date:  2010-08       Impact factor: 5.325

6.  Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.

Authors:  Holm H Uhlig; Fiona Powrie
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

7.  Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved.

Authors:  Takatoshi Chinen; Takashi Kobayashi; Hisanobu Ogata; Giichi Takaesu; Hiromi Takaki; Masayuki Hashimoto; Hideo Yagita; Hajime Nawata; Akihiko Yoshimura
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

8.  Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.

Authors:  Tomohiro Watanabe; Naoki Asano; Peter J Murray; Keiko Ozato; Prafullakumar Tailor; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 9.  Microbiota and mucosal immunity in amphibians.

Authors:  Bruno M Colombo; Thibault Scalvenzi; Sarah Benlamara; Nicolas Pollet
Journal:  Front Immunol       Date:  2015-03-13       Impact factor: 7.561

10.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

View more
  53 in total

1.  Therapy with omeprazole modulates regulatory T cell/T helper 17 immune response in children with duodenal ulcers.

Authors:  Chuan-Ying Li; Cheng Wu
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

Review 2.  Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Authors:  Ross John Porter; Caroline Andrews; Daniel Paul Brice; Scott Kenneth Durum; Mairi Hall McLean
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 5.325

3.  Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B.

Authors:  William van der Touw; Kyeongah Kang; Yi Luan; Ge Ma; Sunny Mai; Lihui Qin; Guanglin Bian; Ruihua Zhang; Sathish Kumar Mungamuri; Hong-Ming Hu; Cheng Cheng Zhang; Stuart A Aaronson; Marc Feldmann; Wen-Chin Yang; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

4.  Retinoic Acid Improves Incidence and Severity of Necrotizing Enterocolitis by Lymphocyte Balance Restitution and Repopulation of LGR5+ Intestinal Stem Cells.

Authors:  Diego F Niño; Chhinder P Sodhi; Charlotte E Egan; Qinjie Zhou; Joyce Lin; Peng Lu; Yukihiro Yamaguchi; Hongpeng Jia; Laura Y Martin; Misty Good; William B Fulton; Thomas Prindle; John A Ozolek; David J Hackam
Journal:  Shock       Date:  2017-01       Impact factor: 3.454

5.  Total CD3 T Cells Are Necessary and Sufficient to Induce Colitis in Immunodeficient Mice With Dendritic Cell-Specific Deletion of TGFbR2: A Novel IBD Model to Study CD4 and CD8 T-Cell Interaction.

Authors:  Deepa Rana Jamwal; Raji V Marati; Christy A Harrison; Monica T Midura-Kiela; Vanessa R Figliuolo Paz; David G Besselsen; Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2020-01-06       Impact factor: 5.325

Review 6.  Extracellular vesicles regulate immune responses and cellular function in intestinal inflammation and repair.

Authors:  Triet M Bui; Lorraine A Mascarenhas; Ronen Sumagin
Journal:  Tissue Barriers       Date:  2018-02-09

Review 7.  Foxp3, Regulatory T Cell, and Autoimmune Diseases.

Authors:  Jin-Hui Tao; Miao Cheng; Jiang-Ping Tang; Qin Liu; Fan Pan; Xiang-Pei Li
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 8.  Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis.

Authors:  Jinlin Miao; Ping Zhu
Journal:  Curr Rheumatol Rep       Date:  2018-04-16       Impact factor: 4.592

9.  DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs.

Authors:  Erin Janssen; Sudha Kumari; Mira Tohme; Sumana Ullas; Victor Barrera; Jeroen Mj Tas; Marcela Castillo-Rama; Roderick T Bronson; Shariq M Usmani; Darrell J Irvine; Thorsten R Mempel; Raif S Geha
Journal:  JCI Insight       Date:  2017-10-05

Review 10.  Inflammatory bowel disease: between genetics and microbiota.

Authors:  Nour Younis; Rana Zarif; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.